EMA issues recommendations on Tysabri and PML
Posted: Thu Jan 21, 2010 11:39 pm
European Medicines Agency issues recommendations following review of Tysabri and PML risk
The European Medicines Agency has finalised a review of Tysabri (natalizumab) and the risk of progressive multifocal leukoencephalopathy (PML), a rare brain infection caused by the JC virus................ http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1905
The European Medicines Agency has finalised a review of Tysabri (natalizumab) and the risk of progressive multifocal leukoencephalopathy (PML), a rare brain infection caused by the JC virus................ http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1905